Aptamer Sciences Calls Extraordinary General Meeting for Reverse Stock Split and Business Expansion: Impact on Shareholder Value

Aptamer Sciences rescheduled its extraordinary general meeting to July 8, 2026 and added agenda items for a reverse stock split and new business purposes.
The reverse stock split consolidates two 500-won shares into one 1,000-won share, halving the number of outstanding shares but leaving market capitalization unchanged.
New business purposes include goods and character product development and e-commerce, signaling diversification beyond its core aptamer technology.
While the reverse split may temporarily boost the stock price, it does not improve fundamental value and the new businesses face high execution risk.
[AI Summary]The reverse split reduces share count and could provide short-term price support, but the addition of low-synergy retail businesses raises concerns about capital allocation and limits long-term shareholder value creation.